PRLD · Prelude Therapeutics Inc
$4.06
-0.14 (-3.33%)
At close · Jul 20
Market Cap
$323.36M
Shares
79.65M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-10 | 2026-06-09 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| DEF 14A | 2026-04-29 | 2026-06-09 | |
| 8-K | 2026-04-21 | 2026-04-20 | |
| 8-K | 2026-04-20 | — | |
| 8-K | 2026-04-15 | — | |
| 8-K | 2026-03-12 | — | |
| 8-K | 2026-03-10 | — | |
| 10-K | 2026-03-10 | 2025-12-31 | |
| 8-K | 2026-02-03 | 2026-01-29 | |
| 8-K | 2026-01-09 | — | |
| Investor Event Transcript | 2025-12-31 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-11-04 | 2025-11-03 | |
| 8-K | 2025-10-17 | 2025-10-15 | |
| 8-K | 2025-09-19 | 2025-09-18 | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-06-13 | 2025-06-11 | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-29 | 2025-06-12 | |
| 8-K | 2025-04-25 | — | |
| 8-K | 2025-03-28 | 2025-03-27 | |
| 10-K | 2025-03-10 | 2024-12-31 | |
| 8-K | 2025-03-10 | — | |
| 8-K | 2025-02-05 | 2025-02-03 | |
| 8-K | 2024-12-11 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-10-24 | — | |
| 8-K | 2024-09-13 | — | |
| 8-K | 2024-09-09 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-08-12 | — | |
| 8-K | 2024-06-18 | 2024-06-14 | |
| 8-K | 2024-06-12 | — | |
| 8-K/A | 2024-05-16 | 2024-04-08 | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-26 | 2024-06-14 | |
| 8-K | 2024-04-10 | 2024-04-08 | |
| 8-K | 2024-02-15 | — | |
| 10-K | 2024-02-15 | 2023-12-31 | |
| 8-K | 2023-12-11 | — | |
| 10-Q | 2023-11-01 | 2023-09-30 |
Showing 1–50 of 101 filings